Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome
被引:249
作者:
Crouser, ED
论文数: 0引用数: 0
h-index: 0
机构:
Ohio State Univ, Med Ctr, Div Pulm & Crit Care Med, Dorothy M Davis Heart & Lung Res Inst 201, Columbus, OH 43210 USAOhio State Univ, Med Ctr, Div Pulm & Crit Care Med, Dorothy M Davis Heart & Lung Res Inst 201, Columbus, OH 43210 USA
Crouser, ED
[1
]
机构:
[1] Ohio State Univ, Med Ctr, Div Pulm & Crit Care Med, Dorothy M Davis Heart & Lung Res Inst 201, Columbus, OH 43210 USA
Sepsis is the leading cause of death in medical intensive care units. In most fatal cases of sepsis the patient experiences an insidious, progressive decline in vital organ function, i.e. multiple organ dysfunction syndrome (MODS), which is commonly associated with signs of accelerated anaerobic metabolism despite supernormal systemic oxygen delivery. Based on this clinical scenario, tissue hypoxia has long been considered the putative mechanism of MODS. However, efforts to enhance tissue oxygenation during severe sepsis have proved ineffective, and a growing body of evidence indicates that mitochondria contribute significantly to the pathogenesis of sepsis-induced MODS. In addition to dysregulation of oxygen metabolism ('cytopathic hypoxia'), sepsis-induced mitochondrial dysfunction contributes to organ injury through accelerated oxidant production and by promoting cell death. Advances in our understanding of the mechanisms of mitochondrial damage and in its detection could revolutionize the management of this devastating disease. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
机构:
Univ Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USAUniv Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA
机构:
Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USAUniv Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA
Bajt, ML
Vonderfecht, SL
论文数: 0引用数: 0
h-index: 0
机构:Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA
Vonderfecht, SL
Jaeschke, H
论文数: 0引用数: 0
h-index: 0
机构:Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA
机构:
Univ Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USAUniv Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO 80262 USA
机构:
Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USAUniv Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA
Bajt, ML
Vonderfecht, SL
论文数: 0引用数: 0
h-index: 0
机构:Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA
Vonderfecht, SL
Jaeschke, H
论文数: 0引用数: 0
h-index: 0
机构:Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA